The future outlook on allergen immunotherapy in children: 2018 and beyond

Allergen immunotherapy (AIT) is the only currently available immune-modifying and aetiological treatment for patients suffering from IgE-mediated diseases. In childhood, it represents a suitable therapeutic option to intervene during the early phases of respiratory allergic diseases such as rhino-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Arasi, Stefania, Corsello, Giovanni, Villani, Alberto, Pajno, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042356/
https://www.ncbi.nlm.nih.gov/pubmed/29996875
http://dx.doi.org/10.1186/s13052-018-0519-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042356/
https://www.ncbi.nlm.nih.gov/pubmed/29996875
http://dx.doi.org/10.1186/s13052-018-0519-4

Ejemplares similares